If you’re diagnosed with cancer, asking which stage is likely one of your first questions. Stage 1 is the earliest, most ...

Combining the two procedures allows for the removal of breast tissue and rebuilding the breast immediately, instead of doing ...

Soon after her diagnosis, Storm’s physician team ordered PreludeDx’s DCISionRT®, the only risk assessment test that predicts radiation therapy (RT) benefit in DCIS patients, to be run on her tumor ...

Actress Danielle Fishel shared her breast cancer diagnosis this week, revealing on Monday’s episode of her podcast, “Pod Meets World,” that she is being treated for ductal carcinoma in situ. “It is ...

Watchful waiting appears to serve women with DCIS just as well as going ahead with surgery Women in active surveillance had the same rate of breast cancer as those who had surgery Both groups also had ...

When 45-year-old Kim Burris was recovering from breast reduction surgery at home in Chapel Hill, she received a call that ...

Patients with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring reported comparable physical, emotional, and psychological outcomes to patients who received upfront treatment, ...

Polygenic scores are a tool that estimates a person’s genetic risk for certain diseases, including breast cancer. Recent ...

A retrospective study found that the 313-SNP breast cancer polygenic risk score (PRS313) blood test could predict future ...

LAGUNA HILLS, Calif., Feb. 12, 2025 /PRNewswire/ — Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, today announced a partnership with Hannah Storm, ...